Answers are grounded in this paper and cite their sources.
Canine adenovirus type 2 (CAV-2) is an important, globally distributed agent of the canine infectious respiratory disease complex (CIRDC). This study investigated CAV-2 in dogs in Vietnam, isolated a field strain, evaluated its replication in three cell lines, and performed whole-genome characterization. PCR targeting the E3 region detected CAV-2 in 17 of 70 (24.3%) clinical swabs from dogs with CIRDC-compatible signs. Partial E3 sequencing of three representative amplicons revealed co-circulation of vaccine-like strains (America–Europe lineage) and wild-type field strains (China–Turkey lineage). A representative field strain, CAV-2/Vietnam/H36/2023, was successfully isolated and serially propagated in MDCK, CRFK, and HeLa cells, producing characteristic cytopathic effects between 48- and 96-h post-inoculation. Illumina sequencing of the third MDCK passage yielded a 31,224-bp genome (50.2% G + C; mean read depth 71,204×), collinear with the reference strain CAV-2/Toronto/A26-61, with conserved gene order, transcriptional orientation, and splicing across all 29 coding sequences. The genome shared 98.84% nucleotide identity with CAV-2/Toronto/A26-61 and was most closely related to recent Chinese field strains. Comparative analysis within 29 coding sequences identified 301 nucleotide substitutions corresponding to 83 amino acid changes, including 82 substitutions and a single in-frame codon deletion (ΔP367) in the pre-terminal protein. Amino-acid substitutions were unevenly distributed and concentrated in the E3 and E4 transcription units and in the L4-22 kDa protein, whereas the major capsid proteins and the protein IX, pVI and Mu peptide precursors remained highly conserved. Phylogenetically, CAV-2/Vietnam/H36/2023 clustered within the China–Turkey lineage with recent Chinese genomes, and no recombination was detected. To our knowledge, this represents the first isolation and whole-genome characterization of a CAV-2 field strain from Vietnam. These findings emphasize the ongoing evolution and genetic diversification of CAV-2, providing a valuable reference for future molecular surveillance, pathogenesis studies, and vaccine efficacy evaluations.
No takes yet. Share an insight, caveat, or question.
Thanh et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: